Leveraging Reverse Transcriptase 2020 | Anton Pozniak

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020

Leveraging Reverse Transcriptase 2020 | Laura Waters

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020

Leveraging Reverse Transcriptase 2020 | Jean-Michel Molina

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020

Leveraging Reverse Transcriptase 2020 | Chloe Orkin

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020

Leveraging Reverse Transcriptase 2020 | Martin Markowitz

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020

Leveraging Reverse Transcriptase 2020 | Daniel Kuritzkes

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020

Leveraging Reverse Transcriptase in HIV | Judith Currier

Leveraging Reverse Transcriptase in HIV: Past, Present, and Future 2020

Debate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain? - Dr. Jürgen Rockstroh Con Standpoint -

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Long-Acting Therapies: Which Patients Will Benefit Most? - Sharon Walmsley

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

HIV and COVID-19 co-infection: An update - Dr. Cristiana Oprea

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Abstract #7 - Development of structural changes in patients treated for VHC in the Czech Republic from viewpoint of stage of liver fibrosis, HCV genotype, age and treatment strategy - Viktor Aster, Charles University, Czech Republic

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Abstract #5 - Quality of lives of PLWHA from Baylor Clinic in Constanta, Romania decreased during the COVID-19 pandemic Ana-Maria Schweitzer, Baylor Black Sea Foundation, Romania

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Abstract #4 - Determination of drug resistance of hepatitis C virus to NS5A protein inhibitors as a new approach to personalized medicine - Elena Gasich, Belarus

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Abstract #3 - Evidence of experience in Community-based HCV Treatment among HIV/HCV Co-infected PWIDs in Ukraine - Zahedul Islam, Alliance Public Health, Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Abstract #2 - A pilot study of the acceptability and feasibility of HCV self-testing among key populations in Georgia - Sonjelle Shilton, FIND, Switzerland

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Abstract # 1 - Characteristics of women diagnosed with HIV in the WHO European Region and predictors of late diagnosis - Otilia Mårdh, ECDC, Sweden

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

The Acute HCV Epidemic in MSM: What Have We Learned Thus Far? - Christoph Boesecke

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Managing Highly Treatment-Experienced Patients: What are the New Drug Options - Prof. Anca Streinu Cercel

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Management of Viral Hepatitis During Pregnancy - Dr. Yvonne Gilleece

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

ART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette Haberl

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

PrEP Implementation in the CEE Region - Prof. Milosz Parczewski

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

2020: Have We Reached the 90-90-90 Targets? - Teymur Noori

Central and Eastern European Meeting on Viral Hepatitis and HIV 2020

Clinical Case: Switching Patients - Including for DDIs (Video) - Pavel Khaykin

Liverpool Course 2020

COVID-19, Me and Clinical Pharmacology (Video) - Dr. Andrea Calcagno

Liverpool Course 2020